-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Solventum, Maintains $100 Price Target

Benzinga·02/27/2026 10:29:50
Listen to the news
BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $100 price target.